Amyloid-Targeting Treatments in Patients With Non–Alzheimer Disease Copathologies

This Viewpoint examines how clinicians should approach amyloid-targeting therapies in patients with Alzheimer disease and suspected copathologies, emphasizing individualized decision-making, current evidence gaps, and the need for prospective studies.